2013-09-02 10:34:55 - Recently published research from GlobalData, "EpiCast Report: Systemic Lupus Erythematosus Epidemiology Forecast to 2022", is now available at Fast Market Research
Systemic lupus erythematosus (SLE) is a chronic autoimmune disease of multifactorial origin that can affect any organ or organ systems, resulting in a broad spectrum of clinical manifestations ranging from dermatological involvement to multi-organ failure with episodes of relapses and remissions. The disease has unpredictable natural course and high rates of morbidity and death The incidence and prevalence of SLE varies globally and the variation is attributed to a combination of elements such as the characteristics of the population studied, sex, ethnicity, geographical locations, occupational factors, familial traits, time period involved, and the diagnostic criteria used. Lupus nephritis (LN) or lupus glomerulonephritis is a serious complication of SLE in which the kidneys are affected.
Full Report Details at
- www.fastmr.com/prod/672861_epicast_report_systemic_lupus_erythem ..
epidemiologists utilized data from country-specific studies published in peer-reviewed journals and governmental documents to provide the age- and sex-specific prevalent cases of diagnosed SLE in the respective markets. The forecast methodology and disease diagnosis criteria were consistent across all of the 7MM to allow for a meaningful comparison among them. The SLE prevalent case forecast followed the 1982 American College of Rheumatology classification and the LN cases were segmented according to the WHO 1982 classification.
The report forecast that 2012 had 452,053 diagnosed prevalent cases of SLE in the 7MM, with approximately 60% of the diagnosed prevalent cases (265,562) in the US alone. GlobalData epidemiologists forecast that there will be 488,769 diagnosed prevalent cases of SLE in the 7MM by 2022, with an overall average annual growth rate (AGR) of 0.81% during the forecast period. GlobalData's epidemiological forecast projected an increase in the diagnosed prevalent cases.
* The Systemic Lupus Erythematosus (SLE) EpiCast Report provides an overview of the risk factors and global trends for SLE for the seven major markets (7MM; US, France, Germany, Italy, Spain, UK, and Japan). GlobalData epidemiologists provide the 10-year epidemiological forecast of the diagnosed prevalent cases of SLE segmented by sex and age and the diagnosed prevalent cases of lupus nephritis (LN) for the 7MM. The prevalent cases of LN in the US, France, Germany, Italy, Spain, and UK are further segmented by severity class (Class I-VI). The EpiCast Report is in-depth, high quality, transparent and market-driven, providing expert analysis of disease trends in the 7MM.
Reasons to Get this Report
The Systemic Lupus Erythematosus EpiCast report will allow you to -
* Develop business strategies by understanding the trends shaping and driving the global SLE market.
* Quantify patient populations in the global SLE to improve product design, pricing, and launch plans.
* Organize sales and marketing efforts by identifying the age groups, sex, and LN class that present the best opportunities for SLE therapeutics in each of the markets covered.
* Identify the percentage of LN prevalent cases in each severity class.
Partial Table of Contents:
1 Table of Contents
1 Table of Contents
1.1 List of Tables
1.2 List of Figures
3.1 Disease Background
3.2 Risk Factors and Comorbidities
3.2.1 Women are at a higher risk of developing SLE than men
3.2.2 Caucasians are at lower risk of developing SLE than other ethnicities
3.2.3 Familial history has been associated with an increased risk of developing SLE
3.2.4 Certain occupational and environmental exposures trigger SLE
3.3 Global Trends
3.4 Forecast Methodology
3.4.1 Sources Used
3.4.2 Sources Not Used
3.4.3 Forecast Assumptions and Methods
3.5 Epidemiological Forecast of SLE (2012-2022)
3.5.1 Diagnosed Prevalent Cases of SLE
3.5.2 Age-Specific Prevalent Cases of SLE
3.5.3 Sex-Specific Prevalent Cases of Diagnosed SLE
3.5.4 Age-Standardized Prevalence of SLE
3.5.5 Diagnosed Prevalent Cases of LN
3.5.6 Prevalent Cases of LN, Segmented by Class
3.6.1 Conclusions on Epidemiology Trends
3.6.2 Limitations of the Analysis
3.6.3 Strengths of the Analysis
4.2 About the Authors
4.2.3 Global Director of Epidemiology and Health Policy
4.2.4 Global Head of Healthcare
4.3 About GlobalData
4.4 About EpiCast
List of Tables
1.1 List of Tables
Table 1: The 1982 Revised ARC Criteria For Classification of Systemic Lupus Erythematosus
Table 2: Risk Factors Associated with SLE
Table 3: World Health Organization Morphologic Classification of Lupus Nephritis (Modified in 1982)
Table 4: Sources of Prevalence Data Used in this Analysis
Table 5: 7MM, Prevalent Cases of Diagnosed SLE, All Ages, Both Sexes, N, Select Years 2012-2022
Table 6: 7MM, Prevalent Cases of Diagnosed SLE, by Age, Both Sexes, N, Row (%), 2012
Table 7: 7MM, Prevalent Cases of Diagnosed SLE, All Ages, by Sex, N, Row (%), 2012
Table 8: 7MM, Prevalent Cases of Diagnosed LN, All Ages, Both Sexes, N, Select Years 2012-2022
Table 9: 6MM, Prevalent Cases in the Different Classes of LN, All Age, Both Sexes, N, Row (%), 2012
List of Figures
1.2 List of Figures
Figure 1: 7MM, Prevalent Cases of Diagnosed SLE, All Ages, Both Sexes, N, 2012-2022
Full Table of Contents is available at:
GlobalData is a leading provider of global business intelligence including market, competitor, product and customer information. It provides in-depth research, analysis, data and forecasts through a range of interactive online databases, reports and management briefings. GlobalData has a large team of experienced research and analysis, consulting, and marketing experts. It has a global presence, including key offices in the US, Europe and Asia. The group has over 50 years of experience of delivering market intelligence data and analysis and a highly experienced senior management team. View more research from GlobalData at www.fastmr.com/catalog/publishers.aspx?pubid=1015
About Fast Market Research
Fast Market Research is an online aggregator and distributor of market research and business information. We represent the world's top research publishers and analysts and provide quick and easy access to the best competitive intelligence available.
For more information about these or related research reports, please visit our website at www.fastmr.com
or call us at 1.800.844.8156.